MDS-1047: RENEW Trial in Progress: A Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate Elritercept in Participants With Transfusion-Dependent Anemia and Lower-Risk Myelodysplastic Neoplasms

Rami S. Komrokji, Jen L. Salstrom, Lynette Chee et al.|Clinical Lymphoma Myeloma & Leukemia|2025

Cited by 0